Evidence map›Paper›PMID 34805998›Full record

ArticleBrain communications2021

NAA80 bi-allelic missense variants result in high-frequency hearing loss, muscle weakness and developmental delay.

Irena J J Muffels, Elsa Wiame, Sabine A Fuchs, Maarten P G Massink, Holger Rehmann, Jiska L I Musch, Gijs Van Haaften, Didier Vertommen, Emile van Schaftingen, Peter M van Hasselt

Open access · goldAbstract read
In one paragraph

Article in Brain communications, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
1.8field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 26 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 5 institutions in 3 countries.

Irena J J MuffelsDepartment of Metabolic Diseases, Division of Pediatrics, Wilhelmina Children's Hospital University Medical Centre Utrecht, Utrecht University, 3584 EA Utrecht, the Netherlands.ORCID https://orcid.org/0000-0002-4335-5034
Elsa WiameLaboratoire de biologie moléculaire, UCLouvain-Cliniques Universitaires Saint-Luc, 1200 Brussels, Belgium.
Sabine A FuchsDepartment of Metabolic Diseases, Division of Pediatrics, Wilhelmina Children's Hospital University Medical Centre Utrecht, Utrecht University, 3584 EA Utrecht, the Netherlands.
Maarten P G MassinkDepartment of Genetics, Section of Genome Diagnostics, Division Laboratories, Pharmacy and Biomedical Genetics, 3584 CX Utrecht, the Netherlands.
Holger RehmannDepartment of Energy and Biotechnology, Flensburg University of Applied Sciences, 24943 Flensburg, Germany.
Jiska L I MuschDepartment of Metabolic Diseases, Division of Pediatrics, Wilhelmina Children's Hospital University Medical Centre Utrecht, Utrecht University, 3584 EA Utrecht, the Netherlands.
Gijs Van HaaftenDepartment of Genetics, Division Laboratories, Pharmacy and Biomedical Genetics, 3584 CX Utrecht, the Netherlands.
Didier VertommenMass Spectrometry Platform, de Duve Institute, UCLouvain, 1200 Brussels, Belgium.ORCID https://orcid.org/0000-0001-7648-8282
Emile van SchaftingenLaboratory of Physiological Chemistry, De Duve Institute, UCLouvain, 1200 Brussels, Belgium.
Peter M van HasseltDepartment of Metabolic Diseases, Division of Pediatrics, Wilhelmina Children's Hospital University Medical Centre Utrecht, Utrecht University, 3584 EA Utrecht, the Netherlands.
Utrecht University · NLde Duve Institute · BECancer Genomics Centre · NLCliniques Universitaires Saint-Luc · BEFlensburg University of Applied Sciences · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The recent identification of NAA80/NAT6 as the enzyme that acetylates actins generated new insight into the process of post-translational actin modifications; however, the role of NAA80 in human physiology and pathology has not been clarified yet. We report two individuals from a single family harbouring a homozygous c.389T>C, p.(Leu130Pro)

Indexed as

actin acetylationactin dynamicsBaraitser-Winterhearing losspost-translational actin modifications

Identifiers

PMID34805998
PMCPMC8599064
OpenAlexW3208965498

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.